Oppenheimer & Co’s Asensus Surgical, Inc. ASXC Stock Holding History

Oppenheimer & Co’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,638	Closed	-$13K	–	1332
2019 Q3	$13K	Sell	1,638 -824	-33%	-$11.2K	﹤0.01%	1246
2019 Q2	$44K	Hold	2,462	–	–	﹤0.01%	1284
2019 Q1	$76K	Buy	2,462 +770	+46%	+$25.8K	﹤0.01%	1315
2018 Q4	$50K	Buy	1,692 +869	+106%	+$39.5K	﹤0.01%	1210
2018 Q3	$62K	Buy	+823	New	+$55.7K	﹤0.01%	1322

Other funds holding ASXC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Oppenheimer & Co's ASXC Position: Q4 2019 in Review

Oppenheimer & Co sold out of Asensus Surgical, Inc. (ASXC) in Q4 2019, closing a stake of 1,638 shares — an estimated $13K sold.

Oppenheimer & Co first reported a position in ASXC in Q3 2018 and held it in 5 quarters. The position peaked at $76K in Q1 2019. 81 funds tracked by Wall St. Rank hold ASXC as of Q4 2019.

Oppenheimer & Co reported no remaining Asensus Surgical, Inc. position as of Q4 2019 after selling out during the quarter.
Oppenheimer & Co sold 1,638 Asensus Surgical, Inc. shares in Q4 2019, an estimated $13K.
Oppenheimer & Co first reported a position in Asensus Surgical, Inc. in Q3 2018 and held it in 5 quarters.
Oppenheimer & Co's Asensus Surgical, Inc. position peaked at $76K in Q1 2019.
81 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q4 2019.

Based on Oppenheimer & Co's 13F filing for Q4 2019, filed 7 Feb 2020.